Which specific glymphatic clearance mechanisms are most therapeutically tractable for enhancing protein aggregate removal?

neuroscience resolved
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
—
Novelty
—
Mechanistic
—
Druggability
—
Priority
85%
Importance
—
Tractability
—
Market price
50%

Description

While glymphatic dysfunction was identified as key to neurodegeneration, the debate did not resolve which molecular components (AQP4 polarization, perivascular flow, CSF pulsatility) offer the best therapeutic targets. This mechanistic gap limits drug development approaches.

Source: Debate session sess_SDA-2026-04-02-gap-20260402-003058 (Analysis: SDA-2026-04-02-gap-20260402-003058)

Evidence summary

Resolved by hypothesis h-var-e2b5a7e7db: GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance. Score: 0.964. Supporting PMIDs: 19449329, 23431156, 26282667, 40994429, 40796363.